RxDoctor Payments DataLook up a doctor →

Tracie Price

Family · Kingsport, TNNPI 1295064798

Payments from drug & device makers

$49,297in general payments, 2019–2025

Across 959 payments — averaging $51.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$30K
  • Biohaven Pharmaceutical Holding Company Ltd.$4K
  • UCB, Inc.$2K
  • MDD US Operations, LLC$957
  • Novartis$953
  • Neurelis, Inc.$803
  • plus $11K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)207$29,526
Biohaven Pharmaceutical Holding Company Ltd.13$3,988
UCB, Inc.87$2,036
MDD US Operations, LLC40$957
Novartis50$953
Neurelis, Inc.27$803
Lundbeck LLC49$761
AstraZeneca(2 entities)34$757
Biogen38$678
Avanir Pharmaceuticals, Inc.5$524
Lilly USA, LLC31$516
Teva Pharmaceuticals USA, Inc.26$470
Eisai Inc.17$392
TG Therapeutics, Inc.15$364
Pfizer25$363
Biohaven Pharmaceuticals, Inc.16$330
Jazz Pharmaceuticals Inc.14$314
Johnson & Johnson14$309
Argenx US, Inc.14$291
Acadia Pharmaceuticals Inc18$283
Amgen12$275
Harmony Biosciences LLC8$265
Neurocrine Biosciences, Inc.14$249
Sanofi12$249
Genentech USA, Inc.13$248
SK Life Science, Inc.11$244
Kyowa Kirin, Inc.9$201
Scilex Pharmaceuticals Inc.10$183
CSL Behring7$182
Grifols USA, LLC10$182
Otsuka America Pharmaceutical, Inc.10$179
Merz Pharmaceuticals, LLC8$177
Catalyst Pharmaceuticals, Inc.8$171
Abbott2$156
Ipsen Biopharmaceuticals, Inc7$155
Amneal Pharmaceuticals LLC8$149
Medtronic5$148
Corium, LLC6$137
Bayer1$125
EMD Serono, Inc.6$105
Sumitomo Pharma America, Inc.8$97
Mallinckrodt Hospital Products Inc.5$87
Impel Pharmaceuticals Inc.3$75
Sunovion Pharmaceuticals Inc.7$74
Idorsia Pharmaceuticals US Inc1$65
Tanabe Pharma America, Inc.4$59
Bristol Myers Squibb3$51
Axsome Therapeutics, Inc.3$50
Takeda Pharmaceuticals U.S.A., Inc.2$49
Amylyx Pharmaceuticals, Inc.1$34
Boston Scientific2$32
Arbor Pharmaceuticals, Inc.2$32
Alnylam Pharmaceuticals Inc.2$31
Supernus Pharmaceuticals, Inc.1$24
Aucta Pharmaceuticals, Inc.1$22
Tonix Medicines, Inc.1$20
Hospira, Inc.1$20
Acorda Therapeutics, Inc1$19
Upsher-smith Laboratories LLC1$16
Sanofi-aventis U.S. LLC1$16

How this compares

$49,297 in reported general payments places this provider in the 95th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$51,425
Medicare patients
245
Services billed
524

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Kingsport

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →